AT160915B - Process for the production of molecular compounds - Google Patents
Process for the production of molecular compoundsInfo
- Publication number
- AT160915B AT160915B AT160915DA AT160915B AT 160915 B AT160915 B AT 160915B AT 160915D A AT160915D A AT 160915DA AT 160915 B AT160915 B AT 160915B
- Authority
- AT
- Austria
- Prior art keywords
- production
- molecular compounds
- ascorbic acid
- desc
- barium
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 title description 5
- 238000004519 manufacturing process Methods 0.000 title description 3
- 150000003839 salts Chemical class 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 4
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 4
- 229910052788 barium Inorganic materials 0.000 description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000010350 erythorbic acid Nutrition 0.000 description 2
- 229940026239 isoascorbic acid Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 229960001404 quinidine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- AKYHKWQPZHDOBW-UHFFFAOYSA-N (5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol Chemical compound OS(O)(=O)=O.C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 AKYHKWQPZHDOBW-UHFFFAOYSA-N 0.000 description 1
- GJHKWLSRHNWTAN-UHFFFAOYSA-N 1-ethoxy-4-(4-pentylcyclohexyl)benzene Chemical compound C1CC(CCCCC)CCC1C1=CC=C(OCC)C=C1 GJHKWLSRHNWTAN-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001576 FEMA 2977 Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960004482 quinidine sulfate Drugs 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 229960003110 quinine sulfate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
<Desc/Clms Page number 1>
Verfahren zur Herstellung von Molekülverbindungen
EMI1.1
nachteiliger physiologischer Wirkungen aufträte.
Es ist a'.'s der österreichischen Patentschrift Nr. 151 127 bekannt, Lösungen der !-Ascorbin- sätie oder Ihrer Analogen mit anorganischen oder organischen Basen teilweise zu neutrali- sieren und sie auf diese Weise zu stabilisieren. Vorteile des vorliegend beschriebenen neuen Verfahrens waren jedoch aus dieser Patentschrift nicht herzuleiten.
Beispiele
EMI1.2
bzw. Chinidinbase. Die Basen lösen sich auf. es entstehen gelbe Lösungen. Diese können unmittelbar verwendet oder es können aus ihnen durch Einengen unter einem indifferenten Gas, wie Stickstoff, die Molckülverbindungen in fester Form gewonnen werden.
EMI1.3
gedampft. Hierauf wird der Trockenrückstand mit Alkohol ausgezogen und durch Einengen die entsprechende Verbindung abgeschieden.
<Desc/Clms Page number 2>
4. 4, 9 g ascorbinsaures Barium werden, unter Durchleiten von Stickstoff in 50 cm3 ausgekochtem, destilliertem Wasser gelöst. Hierauf wird mit einer Lösung von 8,9 g Chinisulfat inog heissem, ausgekochtem, destilliertem Wasser versetzt und sofort abgekühlt. Die entstandene Abscheidung wird nach dem Abkühlen scharf zentrifugiert. Die abgegossene, klare Lösung wird im Vakuum eingeengt. Die Molekulverbindung hinterbieibt als trockenes
Pulver.
In gleicher Weise und in den gleichen Mengenverhältnissen kann. man an Stete von Chininsulfat Chinidinsulfat und an Stelle von ascorbinsaurem Barium isoascorbinsaures Barium anwenden.
PATENTANSPRÜCHE : 1. Verfahren zur Herstellung von Molekülverbindungen, durch Einwirkung von Ascorbinsäure auf organische Basen, dadurch gekennzeichnet, dass man Ascorbins ure. oder Isoascorbin- säure mit Chinin oder Chinidin umsetzt.
**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.
<Desc / Clms Page number 1>
Process for the production of molecular compounds
EMI1.1
adverse physiological effects would occur.
It is known from Austrian patent specification No. 151 127 to partially neutralize solutions of ascorbic acid or its analogues with inorganic or organic bases and to stabilize them in this way. However, advantages of the new method described here could not be derived from this patent specification.
Examples
EMI1.2
and quinidine base, respectively. The bases dissolve. yellow solutions arise. These can be used directly or the Molckülverbindungen can be obtained from them in solid form by concentration under an inert gas such as nitrogen.
EMI1.3
steamed. The dry residue is then extracted with alcohol and the corresponding compound is deposited by concentration.
<Desc / Clms Page number 2>
4. 4.9 g of ascorbic acid barium are dissolved in 50 cm3 of boiled, distilled water while passing nitrogen through. A solution of 8.9 g of quinisulfate in hot, boiled, distilled water is then added and the mixture is immediately cooled. The resulting deposit is sharply centrifuged after cooling. The poured off, clear solution is concentrated in vacuo. The molecular compound remains as a dry one
Powder.
In the same way and in the same proportions. quinidine sulfate is used instead of quinine sulfate and barium isoascorbic acid instead of barium ascorbic acid.
PATENT CLAIMS: 1. Process for the production of molecular compounds by the action of ascorbic acid on organic bases, characterized in that ascorbic acid. or isoascorbic acid with quinine or quinidine.
** WARNING ** End of DESC field may overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT160915T | 1943-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT160915B true AT160915B (en) | 1943-08-24 |
Family
ID=34199655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT160915D AT160915B (en) | 1943-06-24 | 1943-06-24 | Process for the production of molecular compounds |
Country Status (1)
| Country | Link |
|---|---|
| AT (1) | AT160915B (en) |
-
1943
- 1943-06-24 AT AT160915D patent/AT160915B/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT160915B (en) | Process for the production of molecular compounds | |
| AT210573B (en) | Process for the preparation of a new rescinnamine salt | |
| DE712511C (en) | Process for increasing the solubility of caffeine in water | |
| DE374097C (en) | Process for the production of double compounds from caffeine which are easily soluble in water | |
| DE1005729B (en) | Process for the polycondensation of diol esters of aromatic dicarboxylic acids | |
| AT87200B (en) | Process for achieving a permanent, high-yield coating of benzoic acid on paper that is reinforced by additives of a known type in the preservative power. | |
| AT158406B (en) | Process for the preparation of sulfonic acids of higher molecular weight acylated aliphatic amino ethers or their alkali salts. | |
| AT144521B (en) | Method for the preparation of acyloctahydrofollicle hormone. | |
| DE915338C (en) | Process for the preparation of a water-soluble theophylline compound | |
| AT52828B (en) | Process for the preparation of a medicinal product containing citric acid copper as an effective ingredient. | |
| DE974602C (en) | Process for the preparation of 5-nitrofurans alkylated in the 2-position | |
| AT117056B (en) | Process for the preparation of cellulose ethers. | |
| AT120431B (en) | Process for the production of double compounds of urea with sodium iodine. | |
| AT224126B (en) | Process for the preparation of the new optical isomers of 5- (3'-dimethylamino-2'-methylpropyl) -iminodibenzyl | |
| AT162289B (en) | Process for the preparation of esters of 1-alkyl-4-oxypiperidine | |
| AT141164B (en) | Process for the preparation of a compound from acetylsalicylic acid, hexamethylenetetramine and calcium chloride. | |
| DE706341C (en) | Process for the production of water-swollen shrink capsules | |
| DE432420C (en) | Process for the preparation of N-methylsulphurous acid salts of secondary amines | |
| AT147163B (en) | Process for the preparation of organic bismuth compounds. | |
| DE688047C (en) | Process for the production of stable aqueous, therapeutically usable solutions of the polyoxyalkylisoalloxazines | |
| AT117232B (en) | Process for the preparation of salts of antimonic acid and its derivatives. | |
| DE718951C (en) | Process for the preparation of compounds of methyl-p-tolylcarbinol | |
| DE555410C (en) | Process for the preparation of 4-oxy-5-nitroisophthalic acid | |
| AT71175B (en) | Process for the preparation of salizyloyl theobromine. | |
| AT159901B (en) | Process for the preparation of l-ascorbic acid. |